A phase II trial of TS-1 and weelky CDDP combined with hyperthermia as therapy of advanced and relapsed gastric cancer
Phase 2
- Conditions
- Advanced and relapsed gastric cancer
- Registration Number
- JPRN-UMIN000002823
- Lead Sponsor
- Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. TS-1 or CDDP is contraindicated drug 2. With active infection or inflammation 3. With severe heart failure 4. Severe complications 5. With large amout of ascites or pleural effusion 6. With bone metastasis 7. With brain metastasis 8. Active gastrointestinal bleeding needing blood infusion 9. With diarrhea 10.Under treatment with antipsychotic tranquilizer 11. With active double cancer 12.Pregnant or nursing women 13.Men who like be pregnant 14.Inappropriate patients for this study judged by the physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate
- Secondary Outcome Measures
Name Time Method Safety, Overall survival, Progression-free survival time